Local view for "http://purl.org/linkedpolitics/eu/plenary/2014-04-03-Speech-4-223-579"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2014-04-03"^^xsd:date2
dcterms:Is Part Of	lp_eu:Clinical trials on medicinal products for human use (A7-0208/2013 - Glenis Willmott)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20140403.89.4-223-579"2
lpv:hasSubsequent	lp_eu:2014-04-03-Speech-4-223-6702
lpv:speaker	lp:Kay Swinburne2
lpv:spoken text	"I welcome the agreement that has been reached between the institutions on this long-awaited legislation on the clinical trial procedures required before introducing a new medicine to the market. The agreement reached has increased transparency throughout the whole process, which is key to improving public health and advancing science and medicine. I voted in favour of this agreement on the Regulation on clinical trials today as the end report appears balanced and will encourage the adoption of best practice in clinical trials across the EU and beyond."@en1
lpv:spokenAs	substitute; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2012-03-28--2014-06-30)3 substitute; CULT (2012-01-25--2014-06-30)3 substitute; Delegation for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary Committee (2009-09-16--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-10-19--2014-06-30)3 member; ECON (2012-01-19--2014-06-30)3 unknown; Conservative Party (2009-07-14--2014-06-30)3 member; PECH (2009-07-14--2014-06-30)3
lpv:unclassifiedMetadata	"Kay Swinburne (ECR ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph